Human Genome Epidemiology Literature Finder
|
Records 1 - 24 (of 24 Records) |
| Query Trace: Stroke and CYP3A5[original query] |
|---|
| Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2006 Jun 174 (12): 1715-22. Suh Jung-Won, Koo Bon-Kwon, Zhang Shu-Ying, Park Kyung-Woo, Cho Joo-Youn, Jang In-Jin, Lee Dong-Soon, Sohn Dae-Won, Lee Myoung-Mook, Kim Hyo-S |
| Genetic determinants of response to clopidogrel and cardiovascular events. The New England journal of medicine 2009 Jan 360 (4): 363-75. Simon Tabassome, Verstuyft Céline, Mary-Krause Murielle, Quteineh Lina, Drouet Elodie, Méneveau Nicolas, Steg P Gabriel, Ferrières Jean, Danchin Nicolas, Becquemont Laurent, |
| Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009 May 119 (19): 2553-60. Mega Jessica L, Close Sandra L, Wiviott Stephen D, Shen Lei, Hockett Richard D, Brandt John T, Walker Joseph R, Antman Elliott M, Macias William L, Braunwald Eugene, Sabatine Marc |
| Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. Journal of the American College of Cardiology 2011 Jun 57 (25): 2474-83. Campo Gianluca, Parrinello Giovanni, Ferraresi Paolo, Lunghi Barbara, Tebaldi Matteo, Miccoli Matteo, Marchesini Jlenia, Bernardi Francesco, Ferrari Roberto, Valgimigli Mar |
| Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention. Heart (British Cardiac Society) 2012 Sep 98 (18): 1366-72. Park Kyung Woo, Kang Jeehoon, Park Jin Joo, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
| Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese. Neuroreport 2014 May 25 (7): 452-7. Chi Li-Fen, Yi Xing-Yang, Shao Min-Jie, Lin Jing, Zhou Qia |
| Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015 Mar 24 (3): 521-9. Yi Xingyang, Zhang Biao, Wang Chun, Liao Duanxiu, Lin Jing, Chi Lif |
| CYP2C8 rs17110453 and EPHX2 rs751141 two-locus interaction increases susceptibility to ischemic stroke. Gene 2015 Jul 565 (1): 85-9. Yi Xingyang, Zhang Biao, Wang Chun, Liao Duanxiu, Lin Jing, Chi Lif |
| Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 Sep . Yi Xingyang, Han Zhao, Zhou Qiang, Cheng Wen, Lin Jing, Wang Ch |
| Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016 Aug . Yi Xingyang, Zhou Qiang, Wang Chun, Lin Jing, Cheng Wen, Chi Lif |
| Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke. Journal of atherosclerosis and thrombosis 2016 Mar . Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Qiang, Wang Chun, Cheng Wen, Chi Lif |
| Interaction among CYP2C8, GPIIIa and P2Y12 variants increase susceptibility to ischemic stroke in Chinese population. Oncotarget 2017 Sep 8 (41): 70811-70820. Yi Xingyang, Lin Jing, Wang Yanfen, Zhou Ju, Zhou Qia |
| Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saedi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
| Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke. Pharmacogenomics and personalized medicine 2018 4 11 43-49. Kryukov Alexander Valerevich, Sychev Dmitry Alekseevich, Andreev Denis Anatolevich, Ryzhikova Kristina Anatolievna, Grishina Elena Anatolievna, Ryabova Anastasia Vladislavovna, Loskutnikov Mark Alekseevich, Smirnov Valeriy Valerevich, Konova Olga Dmitrievna, Matsneva Irina Andreevna, Bochkov Pavel Olegovi |
| Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of thrombosis and thrombolysis 2019 Sep . Gulilat Markus, Keller Denise, Linton Bradley, Pananos A Demetri, Lizotte Daniel, Dresser George K, Alfonsi Jeffrey, Tirona Rommel G, Kim Richard B, Schwarz Ute |
| Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke. Current pharmaceutical design 2019 Jul . Zhang Limin, Lv Hong, Zhang Qian, Wang Dongzhi, Kang Xixiong, Zhang Guojun, Li Xinga |
| Association of CYP3A4*1G and CYP3A5*3 With the 1-year Outcome of Acute Ischemic Stroke in the Han Chinese Population. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2019 May . Li Shuo, Shi Chang-He, Liu Xin-Jing, Li Yu-Sheng, Li Shao-Hua, Song Bo, Xu Yu-Mi |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| Effects of CYP3A4*22 and CYP3A5 on clinical outcome in patients treated with ticagrelor for ST-segment elevation myocardial infarction: POPular Genetics sub-study. Frontiers in pharmacology 2022 12 13 1032995. Azzahhafi Jaouad, Bergmeijer Thomas O, van den Broek Wout W A, Chan Pin Yin Dean R P P, Rayhi Senna, Peper Joyce, Bor Willem L, Claassens Daniel M F, van Schaik Ron H N, Ten Berg Jurriën |
| Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients. Frontiers in pharmacology 2022 12 13 1007113. Campos-Staffico Alessandra M, Dorsch Michael P, Barnes Geoffrey D, Zhu Hao-Jie, Limdi Nita A, Luzum Jasmine |
| Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events. Frontiers in genetics 2022 10 13 982955. Attelind Sofia, Hallberg Pär, Wadelius Mia, Hamberg Anna-Karin, Siegbahn Agneta, Granger Christopher B, Lopes Renato D, Alexander John H, Wallentin Lars, Eriksson Nicl |
| ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban. Drug design, development and therapy 2023 8 17 2513-2522. Hamin Kim, Tae-Jin Song, Jeong Yee, Dong-Hyeok Kim, Junbeom Park, Hye Sun Gw |
| CYP metabolic pathway related gene polymorphism increases the risk of embolic and atherothrombotic stroke and vulnerable carotid plaque in southeast China. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2023 5 32 (8): 107195. Minjie Shao, Youbing Mao, Qing Hong, Xinchun Jin, Haibo Cai, Xingyang |
| [Analysis of the association of CYP450 gene polymorphisms with ischemic stroke]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 500-504. Qi Lin, Liu Yongfang, Qi Meng, Peng Yingjuan, Sun Guangming, Yue Yi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: